¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"multiple endocrine deficiency syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • deficit syndrome
    °áÇÌÁõÈıº
  • dysarthria clumsy hand syndrome
    Á¶À½Àå¾Ö¼­Å÷¼ÕÁõÈıº
  • delayed sleep phase syndrome
    ¼ö¸éÀ§»óÁö¿¬ÁõÈıº
  • Dandy-Walker syndrome
    ´íµð-¿öÄ¿ÁõÈıº
  • dead-in-bed syndrome
    ħ´ë»ç¸ÁÁõÈıº
  • dialysis disequilibrium syndrome
    Åõ¼®ºÒ±ÕÇüÁõÈıº
  • Diamond-Blackfan syndrome
    ´ÙÀ̾Ƹóµå-ºí·¢ÆÇÁõÈıº
  • Down syndrome
    ´Ù¿îÁõÈıº
  • exfoliation syndrome
    ¹ÚÅ»ÁõÈıº
  • ectrodactyly-ectodermal dysplasia clefting syndrome
    °áÁö¿Ü¹è¿±Çü¼ºÀ̻󰥸²ÁõÈıº
  • extrapyramidal syndrome
    ÇǶó¹Ìµå¹Ù±ù±æÁõÈıº, Ãßü¿Ü·ÎÁõÈıº
  • empty nest syndrome
    ºóµÕÁöÁõÈıº
  • empty sella syndrome
    ºó¾ÈÀåÁõÈıº
  • entrapment syndrome
    Æ÷ÂøÁõÈıº
  • eosinophilia-myalgia syndrome
    È£»ê±¸Áõ°¡±Ù(À°)ÅëÁõÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • chromosomal breakage syndrome
    ¿°»öüÆÄ¼ÕÁõÈıº, ¿°»öüºÒ¾ÈÁ¤ÁõÈıº
  • chronic fatigue syndrome
    ¸¸¼ºÇÇ·ÎÁõÈıº
  • chronic pain syndrome
    ¸¸¼ºÅëÁõÁõÈıº
  • clinical syndrome
    ÀÓ»óÁõÈıº
  • clumsy child syndrome
    µÐÇѾƵ¿ÁõÈıº
  • clumsy hand syndrome
    ¼­Å÷¼ÕÁõÈıº
  • co-contraction syndrome
    µ¿½Ã¼öÃàÁõÈıº
  • combined immunodeficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº
  • compartment syndrome
    ±¸È¹ÁõÈıº
  • complex regional pain syndrome
    º¹ÇÕ±¹¼Òµ¿ÅëÁõÈıº
  • compression syndrome
    ¾Ð¹ÚÁõÈıº
  • concentration camp syndrome
    ¼ö¿ë¼ÒÁõÈıº
  • congenital constriction ring syndrome
    ¼±ÃµÇùÂø°í¸®ÁõÈıº
  • cor pulmonale syndrome
    Æó½ÉÀåÁõÈıº, ÇãÆÄ½ÉÀåÁõÈıº
  • cord compression syndrome
    ô¼ö¾Ð¹ÚÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • Downs syndrome
    ´Ù¿îÁõÈıº
  • Downs syndrome
    ´Ù¿î ÁõÈıº
  • Duanes retraction syndrome
    µà¾È¾È±¸ÈÄÅðÁõÈıº
  • Dubin-Johnson syndrome
    µàºó-Á¸½¼ÁõÈıº.
  • Edwards syndrome
    ¿¡µå¿öÁîÁõÈıº.
  • Ehlers-Danlos syndrome
    ¿¤·¯½º-´Ü·Î½º ÁõÈıº
  • Fanconi syndrome
    ÆÇÄÚ´Ï ÁõÈıº(ñøý¦ÏØ)
  • Fanconis syndrome
    ÆÇÄÚ´ÏÁõÈıº
  • Feltys syndrome
    ÆçƼÁõÈıº
  • Forster-Kennedy syndrome
    Æ÷½ºÅÍ-Äɳ׵ð ÁõÈıº
  • Froin syndrome
    ÇÁ·Î¾ÞÁõÈıº
  • Gaisb cks syndrome
    °¡À̽ººÆÅ©ÁõÈıº
  • Ganser syndrome
    °µ¼­ÁõÈıº(~ñøý¦ÏÛ)
  • Ganser syndrome
    °µ¼­ÁõÈıº.
  • Gardner s syndrome
    °¡¾Æµå³ÊÁõÈıº.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • multiple neuroma =neuromatosis
    ´Ù¹ß¼º ½Å°æÁ¾(¡­ãêÌèðþ).
  • multiple neuroma =neuromatosis
    ´Ù¹ß¼º ½Å°æÁ¾(¡­ãêÌèðþ)
  • multiple nodular goiter
    ´Ù¹ß¼º °áÀý¼º °©»ó¼±Á¾(ÒýÛ¡àõÌ¿ï½àõË£ßÒàÍðþ).
  • multiple nodular goiter
    ´Ù¹ß¼º °áÀý¼º °©»ó¼±Á¾(¡­Ì¿ï½àõË£ßÒàÍðþ)
  • multiple nodular goiter
    ´Ù¹ß¼º °áÀý¼º °©»ó¼±Á¾(´Ù¹ß¼º°áÀý¼º°©»ó¼±Á¾).
  • multiple organ dysfunction
  • multiple overlapping thin slab acquisition (MOTSA)
    ´ÙÁß Áߺ¹ ¼¼ÆíÆÇ ȹµæ
  • multiple paramyoclonus
    ´Ù¹ß¼º ±Ù°£´ë°æ·Ã(ÒýÛ¡àõÐÉÊàÓÛÌâÕý).
  • multiple personality
  • multiple personalty disorder
  • multiple petechia
    ´Ù¹ß¼º Á¡»óÃâÇ÷(¡­ïÇßÒõóúì)
  • multiple placenta
    ¹µÅ¹Ý
  • multiple polyp
    ´Ù¹ß¼º(ÒýÛ¡àõ) Æú¸³.
  • multiple polyp
    ´Ù¹ß¼º Æú¸³
  • multiple polyp
    ´Ù¹ß¼º(´Ù¹ß¼º) Æú¸³.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
PLWA person living with acquired immune deficiency syndrome
pre-AIDS pre-acquired immune deficiency syndrome
SYDS stomach yin deficiency syndrome
YDYES yin deficiency yang excess syndrome
AAS Aarskog-Scott [syndrome]; acid aspiration syndrome; alcoholic abstinence syndrome; American Academy ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
PFFD Proximal femoral focal deficiency
PTD Pyrithiamine-induced thiamine deficiency
SCID Severe Combined Immune Deficiency
TD Thiamine deficiency
VAD Vitamin A deficiency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • anxiety syndrome
    °í¹Î ÁõÈıº, ºÒ¾È ÁõÈıº
    Á¤½ÅÀû °í¹Î¿¡ ¼ö¹ÝÇÏ´Â ÁõÈıºÀ¸·Î, ½É°èÇ×Áø, È£Èí°ï¶õ, ¹ßÇÑ, ¾È»ö â¹é, °øÆ÷ µîÀ» ³ªÅ¸³½´Ù.
  • aortitis syndrome
    ´ëµ¿¸Æ¿° ÁõÈıº
  • apallic syndrome
    ¹«½É ÁõÈıº
  • apathetic-akinetic syndrome
    ¹«°¨µ¿-¹«µ¿ÀÛ ÁõÈıº
  • Apert syndrome
    ¿¡ÆÛÆ® ÁõÈıº, ¾ÆÆä¸£Æ® ÁõÈıº
    ÀÓ»óÀûÀ¸·Î µÎ°³°ñ ºÀÇÕÀÇ Á¶±â Æó¼â·Î ÀÎÇÑ µÎ°³ ±âÇü, ¾È¸é Á߾ӺΠÇü¼º ºÎÀü, ¾çÃø¼º ÇÕÁöÁõÀ¸·Î Á¤ÀǵȴÙ. µå¹® Àå¾Ö·Î¼­ ¶§·Î »ó¿°»öü ¿ì¼º À¯ÀüÀÌ °üÂûµÇ±âµµ Çϳª º¸ÅëÀº »ê¹ßÀûÀÎ µ¹¿¬º¯ÀÌ¿¡ ÀÇÇØ ¹ß»ýµÈ´Ù.
  • arthritis-dermatitis syndrome
    °üÀý¿°-ÇǺο° ÁõÈıº
  • Ashermans syndrome
    ¾Æ¼Å¸¸ ÁõÈıº
    Àڱó» ¿ìÂø¿¡ ÀÇÇÏ¿© Áö¼Ó¼º ¹«¿ù°æ°ú ÀÌÂ÷¼º ºÒÀÓÀÌ ³ªÅ¸³ª´Â °Í. º¸Åë Àڱó» ¼ÒÆÄÀÇ °á°ú·Î ÀϾ´Ù.
  • atypical or mixed organic brain syndrome
    ºñÁ¤Çü ³»Áö È¥ÇÕÇü ±âÁú¼º ³ú ÁõÈıº
  • atypical schizophrenic syndrome
    ºñÁ¤Çü Á¤½ÅºÐ¿­¼º ÁõÈıº
  • autoerythrocyte sensitization syndrome
    ÀÚ°¡ ÀûÇ÷±¸ °¨ÀÛ ÁõÈıº
    ÁÖ·Î ÀþÀº ¿©ÀÚ¿¡°Ô º¼ ¼ö ÀÖ´Â ÀÚ¹Ý ¹ÝÀÀÀÇ ÀÏÁ¾À¸·Î ¿Ü»ó ¾øÀÌ ¶Ç´Â ºÒ¿ÏÀü ¿Ü»ó ÈÄ ½Åü¿¡ ÀÚ¿¬ÀûÀ¸·Î µ¿ÅëÀ» µ¿¹ÝÇÏ°í ¹Ýº¹ÇÏ¿© ´Üµ¶ ¶Ç´Â ´Ù¹ß¼º ¹Ý»ó ÃâÇ÷ÀÌ ³ªÅ¸³­´Ù. ¸¹Àº Áõ·Ê¿¡¼­ ÀûÇ÷±¸ ±¸¼º ¼ººÐ¿¡ ´ëÇÑ °ú¹Î¼ºÀÌ ¿øÀÎÀ¸·Î »ý°¢µÇ³ª, ¹éÇ÷±¸°¡ ¿øÀÎÀ¸·Î »ý°¢µÇ´Â ¿¹µµ ÀÖ´Ù. Á¤¼­Àû Àå¾Ö°¡ ¹ßº´ °á½Ç ÀÎÀÚ·Î º¸ÀδÙ.
  • Axenfeld syndrome
    ¾Ç¼¾ÆçÆ® ÁõÈıº
  • B-K mole syndrome
    B-K ¸ð¹Ý ÁõÈıº
  • Barters syndrome
    ¹ÙÅÍ ÁõÈıº
  • basal ganglion calcification syndrome
    ±âÀú ½Å°æÀý ¼®È¸È­ ÁõÈıº
  • battered child syndrome
    ÇÇÇÐ´ë¾Æ ÁõÈıº, ¾Æµ¿ Çдë ÁõÈıº, ¼Ò¾Æ Çдë ÁõÈıº
    ¾Æµ¿ÀÇ »À ¹× ¿¬ºÎ Á¶Á÷¿¡ ´Ù¼öÀÇ ¿Ü»ó¼º º´º¯À» ³ªÅ¸³»´Â °ÍÀ¸·Î¼­ Á¾Á¾ °æ¸·ÇÏ Ç÷Á¾À» ¼ö¹ÝÇÑ´Ù. ÀÌ·± º´º¯Àº º¸Åë ¼ºÀÎÀÇ °íÀÇÀûÀÎ °¡ÇØ¿¡ ÀÇÇØ »ý±ä´Ù. ºÎ¸ðµéÀÌ 3¼¼ ÀÌÇÏ Æ¯È÷ 1¼¼ ÀÌÇÏÀÇ À¯¾Æ¸¦ ¹«ºÐº°ÇÏ°Ô ¶§¸®°Å³ª ±âŸ ¹æ¹ýÀ¸·Î ÇдëÇÔÀ¸·Î½á ÀϾ´Â ½Åü Áõ»ó. ¹Ì±¹ÀÇ ¼Ò¾Æ°ú ÀÇ»ç H. ÄÍÇÁ µîÀÌ ¹Ì±¹ Àü¿ª¿¡ °ÉÃÄ Á¶»çÇÏ¿´À¸¸ç, 1962³âÀÌ·¡ ¼±Áø Á¦±¹¿¡ ³Î¸® ¾Ë·ÁÁø Çö»óÀÌ´Ù. ÁÖ·Î, ¨ç ÇÇÇÏ ÃâÇ÷, Àý»ó, È­»ó µîÀÇ ÇǺΠÁõ¼¼, ¨è Àü½ÅÀÇ °ñÀý, Å»±¸, ¨é µÎ°³³» ÃâÇ÷À̳ª °æ¸·ÇÏÇ÷Á¾, ¨ê Àå±â ÆÄ¿­ ¹× ³»ÃâÇ÷ µî º¹ºÎÀÇ ¼Õ»ó, ¨ë ¼ºÀå ¹ß´Þ ÀåÇØ µîÀ» º¼ ¼ö ÀÖ´Ù. À̰ÍÀº ¿À´Ã³¯ÀÇ ¼±Áø Á¦±¹ÀÇ ±Þ¼ÓÇÑ °¡Á¤ ºØ±« Çö»ó°ú °ü·ÃÇÏ¿© ÀϾ´Â Áõ¼¼ÀÌ´Ù. ºÎºÎ°£ÀÇ °¥µîÀÌ ±Ø½ÉÇØÁö¸é À̵éÀº ¼­·Î °£ÆíÇÏ°Ô Çì¾îÁ®¾ß ÇÑ´Ù°í »ý°¢Çϰí À̶§ ¾î¸°¾ÆÀ̵éÀÌ Àå¾Ö¹°À̶ó ¹Ï°Ô µÇ¾î ¾Æ¹« ÁË ¾ø´Â ¾ÆÀ̵éÀ» ¸¶±¸ ÆøÇàÇÏ´Â µîÀÇ ÇдëÇàÀ§°¡ ³ªÅ¸³­´Ù. Çд븦 °¡ÇÏ´Â ºÎ¸ðµéÀº Á¤¼­ÀûÀ¸·Î ¹Ì¼÷ÇÑ È÷½ºÅ׸® ¼º°ÝÀÚ, ¼ºÀû ºÒ°¨Áõ, °ø°Ý¼º ¼º°ÝÀÚ, ¾ËÄÚ¿Ã Áßµ¶ÀÚ, ¸Á»óÇüÀÇ Á¤½ÅºÐ¿­Áõ ȯÀÚ µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. À̶§ Çд븦 ¹ÞÀº ¾ÆÀ̵éÀº Á¤½Å ¹ß´Þ Àå¾ÖÁõ, ¹ÝÇ×Àû ¼º°Ý, °íÁýÀÌ ¼¾ Ç×¹®±âÀû °íÂøÁõ µîÀÇ Æ¯Â¡À» ³ªÅ¸³½´Ù. ÀÌ·¯ÇÑ Çö»óÀº Çѱ¹ÀÇ »çȸ ¹®È­¿¡¼­´Â ¾ÆÁ÷ Èñ±ÍÇÏÁö¸¸ ±Ù´ëÈ­, ÇÙ°¡Á·È­, ¿©±ÇÀÇ ½ÅÀå, ¾ËÄÚ¿Ã Àα¸ÀÇ Áõ°¡, »çȸÀû ½ºÆ®·¹½º ¿äÀÎÀÇ Áõ´ë·Î Á¡Á¡ Áõ°¡µÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
muscle phosphorylase deficiency Type V glycogen storage disease, affecting muscle, caused by deficiency of muscle phosphorylase.
(05 Mar 2000)
myophosphorylase deficiency glycogenosis Glycogenosis due to muscle glycogen phosphorylase deficiency, resulting in accumulation of glycogen of normal chemical structure in muscle.
Synonym: McArdle's disease, McArdle's syndrome, McArdle-Schmid-Pearson disease, myophosphorylase deficiency glycogenosis.
(05 Mar 2000)
potassium deficiency A condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhoea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing polyuria and decreased maximal urinary concentrating ability with secondary polydipsia. (merck manual, 16th ed)
(12 Dec 1998)
hageman factor deficiency A deficiency of a specific blood clotting factor (XII) that may be genetic or acquired. Administration of heparin or severe liver disease may result in factor XII (Hageman factor) deficiency. There are usually no symptoms associated with this deficiency, but there may be symptoms of mild blood loss in some cases. Treatment is generally unnecessary. Individuals should be cautioned against the use of medications (for example aspirin, warfarin, heparin) with anticoagulant activity, due to risk of exaggerated effects.
(27 Sep 1997)
hepatophosphorylase deficiency glycogenosis Glycogenosis due to hepatic glycogen phosphorylase deficiency, resulting in accumulation of glycogen of normal chemical structure in liver and leukocytes.
Synonym: hepatophosphorylase deficiency glycogenosis, Hers' disease.
(05 Mar 2000)
protein c deficiency Protein C is a protein in plasma that enters into the cascade of biochemical events leading to the formation of a clot. Deficiency of protein c results in thrombotic (clotting) disease and excess platelets with recurrent thrombophlebitis (inflammation of the vein that occurs when a clot forms). The clot can break loose and travel through the blood stream (thromboembolism) to the lungs causing a pulmonary embolism, brain causing a stroke (cerebrovascular accident), heart causing an early heart attack, skin causing what in the newborn is called neonatal purpura fulminans, the adrenal gland causing haemorrhage with abdominal pain, abnormally low blood pressure (hypotension), and salt loss. Protein c deficiency is due to possession of one gene (heterozygosity) in chromosome band 2q13-14. The possession of two such genes (homozygosity) is usually lethal.
(12 Dec 1998)
protein deficiency A nutritional condition produced by a deficiency of proteins in the diet, characterised by adaptive enzyme changes in the liver, increase in amino acid synthetases, and diminution of urea formation, thus conserving nitrogen and reducing its loss in the urine. Growth, immune response, repair, and production of enzymes and hormones are all impaired in severe protein deficiency. Protein deficiency may also arise in the face of adequate protein intake if the protein is of poor quality (i.e., the content of one or more amino acids is inadequate and thus becomes the limiting factor in protein utilization).
(12 Dec 1998)
protein s deficiency An autosomal dominant disorder showing decreased levels of plasma protein s antigen or activity, associated with venous thrombosis and pulmonary embolism. Protein s is a vitamin k-dependent plasma protein that inhibits blood clotting by serving as a cofactor for activated protein c (also a vitamin k-dependent protein), and the clinical manifestations of its deficiency are virtually identical to those of protein c deficiency. Treatment with heparin for acute thrombotic processes is usually followed by maintenance administration of coumarin drugs for the prevention of recurrent thrombosis.
(12 Dec 1998)
prothrombin deficiency A congenital or acquired disorder of blood clotting where there is a deficiency of factor II (prothrombin), one of 20 necessary plasma proteins for normal blood coagulation. Acquired factor II deficiency may result from vitamin K deficiency, severe liver disease and anticoagulant drugs.
Symptoms include abnormal bleeding, nosebleeds, abnormal menstrual bleeding, easy bruising and umbilical cord bleeding at birth. Treatment involves the infusion of fresh frozen plasma. Vitamin K may be administered in select cases.
(27 Sep 1997)
proximal femoral focal deficiency A congenital defect in which variable portions of the upper end of the femur are reduced or absent.
(05 Mar 2000)
pseudocholinesterase deficiency An autosomal dominant disorder manifested by exaggerated responses to drugs ordinarily hydrolyzed by serum pseudocholinesterase (e.g., succinylcholine); believed to entail production of a variant enzyme that is less active than the normal enzyme in hydrolyzing appropriate substrates, but also abnormally resistant to the effects of anticholinesterases.
(05 Mar 2000)
secondary antibody deficiency Immunodeficiency in which there is no evident defect in the lymphoid tissues, but rather hypercatabolism or loss of immunoglobulins such as occurs in familial idiopathic hypercatabolic hypoproteinaemia or in defects associated with the nephrotic syndrome.
Synonym: secondary agammaglobulinaemia, secondary antibody deficiency, secondary hypogammaglobulinaemia.
(05 Mar 2000)
selective immunoglobulin A deficiency <immunology> An inherited disorder in which there is a markedly reduced or absent IgA, resulting in immature IgA-bearing B-cells.
(05 Mar 2000)
selenium deficiency deficiency of the essential mineral selenium causes keshan disease, a fatal form of cardiomyopathy (disease of the heart muscle) first observed in keshan province in china and since found elsewhere. According to the national academy of sciences, the recommended dietary allowances of selenium are 70 milligrams per day for men and 55 milligrams per day for women. Food sources of selenium include seafoods, some meats such as kidney and liver, and some grains and seeds
(12 Dec 1998)
pyridoxine deficiency A nutritional condition produced by a deficiency of pyridoxine in the diet, characterised by dermatitis, glossitis, cheilosis, and stomatitis. Marked deficiency causes irritability, weakness, depression, dizziness, peripheral neuropathy, and seizures. In infants and children typical manifestations are diarrhoea, anaemia, and seizures. Increasingly recognised as a cause is prolonged therapy with certain medications, among them isoniazid, cycloserine, and l-dopa.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á